Daily tablet shows promise in treating achondroplasia in children

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study.

Intellia’s gene editing therapy shows early potential in rare heart condition – Pharmaceutical Technology

Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) presents with symptoms primarily related to heart failure and impaired cardiac function. Credit: Rawpixel.com via Shutterstock. Intellia Therapeutics has announced

November 18, 2024

Rethinking the internet’s role in mental health: Recent study challenges common perceptions

Researchers examined the impact of the growth in internet technology on psychological well-being and overall mental health.

November 30, 2023

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

Mary Brown was sipping coffee at home in Ontario, Calif., Sunday morning when a friend sent a video clip that ruined her breakfast. It contained

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.